The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
Open accessAbstract
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with high mortality. We used a systematic drug repositioning bioinformatics approach querying a large compendium of gene expression profiles to identify candidate U.S. Food and Drug Administration (FDA)–approved drugs to treat SCLC. We found that tricyclic antidepressants and related molecules potently induce apoptosis in both chemonaïve and chemoresistant SCLC cells in culture, in mouse and human SCLC tumors transplanted into immunocompromised mice, and in endogenous tumors from a mouse model for human SCLC. The candidate drugs activate stress pathways and induce cell death in SCLC cells, at least in part by disrupting autocrine survival signals involving neurotransmitters and their G protein–coupled receptors. The candidate drugs inhibit the growth of other neuroendocrine tumors, including pancreatic neuroendocrine tumors and Merkel cell carcinoma. These experiments identify novel targeted strategies that can be rapidly evaluated in patients with neuroendocrine tumors through the repurposing of approved drugs. Significance: Our work shows the power of bioinformatics-based drug approaches to rapidly repurpose FDA-approved drugs and identifies a novel class of molecules to treat patients with SCLC, a cancer for which no effective novel systemic treatments have been identified in several decades. In addition, our experiments highlight the importance of novel autocrine mechanisms in promoting the growth of neuroendocrine tumor cells. Cancer Discov; 3(12); 1364–77. ©2013 AACR. See related commentary by Wang and Byers, p. 1333 This article is highlighted in the In This Issue feature, p. 1317
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Function and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127
Hanahan, D. (1985) · Nature · doi:10.1038/315115a0 · Cited by 1,281
van Meerbeeck, J. P., Fennell, D. A., & De Ruysscher, D. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60165-7 · Cited by 1,237
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Self-citationLee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M., Sorger, P. K., MacBeath, G., & Yaffe, M. B. (2012) · Cell · doi:10.1016/j.cell.2012.03.031 · Cited by 680
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 605
Self-citationDistribution, properties, and functional characteristics of three classes of histamine receptor.
Hill, S. J. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00039-0 · Cited by 591
Byers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J., Giri, U., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 557
Lopez-Munoz, F., & Alamo, C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168001 · Cited by 476
Molecular genetics of small cell lung carcinoma
WISTUBA, I. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90072-7 · Cited by 421
Fribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.055 · Cited by 311
Systematic Drug Repositioning Based on Clinical Side-Effects
Yang, L., & Agarwal, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028025 · Cited by 266
Schröder, R., Janssen, N., Schmidt, J., Kebig, A., Merten, N., Hennen, S., Müller, A., Blättermann, S., Mohr-Andrä, M., Zahn, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1671 · Cited by 256
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Schaffer, B. E., Park, K.-S., Yiu, G., Conklin, J. F., Lin, C., Burkhart, D. L., Karnezis, A. N., Sweet-Cordero, E. A., & Sage, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4228 · Cited by 253
Self-citationA crucial requirement for Hedgehog signaling in small cell lung cancer
Park, K.-S., Martelotto, L. G., Peifer, M., Sos, M. L., Karnezis, A. N., Mahjoub, M. R., Bernard, K., Conklin, J. F., Szczepny, A., Yuan, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2473 · Cited by 247
Self-citationManagement of Small Cell Lung Cancer
Simon, G. R., & Turrisi, A. (2007) · Chest · doi:10.1378/chest.07-1385 · Cited by 226
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
Heasley, L. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204183 · Cited by 199
SnapShot: Non-Small Cell Lung Cancer
Heist, R. S., & Engelman, J. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.007 · Cited by 196
Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion
Li, L., & Hanahan, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.051 · Cited by 192
Gerits, N., Kostenko, S., Shiryaev, A., Johannessen, M., & Moens, U. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.022 · Cited by 182
Song, P., Sekhon, H. S., Lu, A., Arredondo, J., Sauer, D., Gravett, C. A., Mark, G. P., Grando, S. A., & Spindel, E. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2484 · Cited by 149
Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis
McEvoy, J. D., Flores‐Otero, J., Zhang, J., Nemeth, K. M., Brennan, R. C., Bradley, C. L., Krafcik, F., Galindo, C. R., Wilson, M. W., Xiong, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.005 · Cited by 141
Self-citationNeuropeptides as Autocrine Growth Factors in Cancer Cells
Moody, T. W., Chan, D. C. F., Fahrenkrug, J., & Jensen, R. T. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391621 · Cited by 140
Perry, P. J., ZEILMANN, C., & Arndt, S. V. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199408000-00002 · Cited by 137
A Computational Approach to Finding Novel Targets for Existing Drugs
Li, Y. Y., An, J., & Jones, S. J. M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002139 · Cited by 129
Molecular Target Class Is Predictive of In vitro Response Profile
Greshock, J. D., Bachman, K. E., Degenhardt, Y., Jing, J., Wen, Y. H., Eastman, S. D., McNeil, E., Moy, C. H., Wegrzyn, R. J., Auger, K. R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3788 · Cited by 124
Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD
Walker, A. J., Card, T. R., Bates, T. E., & Muir, K. R. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605996 · Cited by 122
Chen, G., Hasanat, K., Bebchuk, J. M., Moore, G. J., Glitz, D. A., & Manji, H. K. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00004 · Cited by 113
The G protein-coupled receptors: Pharmacogenetics and Disease
Thompson, M. D., Burnham, W. M., & Cole, D. E. C. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360591001895 · Cited by 104
Antipsychotics in bipolar disorder.
Rasenick, M. M., Chaney, K. A., & Chen, J. (1996) · PubMed · Cited by 104
Signalling specificity in GPCR-dependent Ca2+ signalling
Kiselyov, K. I., Shin, D. M., & Muallem, S. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00074-8 · Cited by 100
G protein signaling and the molecular basis of antidepressant action
Donati, R. J., & Rasenick, M. M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00249-2 · Cited by 100
Neuronal characteristics of small-cell lung cancer
Onganer, P. U., Seckl, M. J., & Djamgoz, M. B. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602857 · Cited by 94
Recent progress in alpha1-adrenergic receptor research
Chen, Z., & Minneman, K. P. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00224.x · Cited by 90
Antiallergic Anti-Inflammatory Effects of H1-Antihistamines in Humans
Assanasen, P., & Naclerio, R. M. (2002) · CRC Press eBooks · doi:10.3109/9780203910375-9 · Cited by 82
Rohrbeck, A., Neukirchen, J., Rosskopf, M., Pardillos, G. G., Geddert, H., Schwalen, A., Gabbert, H. E., von Haeseler, A., Pitschke, G., Schott, M., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-69 · Cited by 64
Current Management of Small Cell Lung Cancer
Neal, J. W., Gubens, M. A., & Wakelee, H. A. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.07.002 · Cited by 41
Self-citationAdjuvant and neoadjuvant therapy in prostate cancer
Chay, C. H. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90041-7 · Cited by 35
Distinct roles of cholinergic receptors in small cell lung cancer cells.
Zhang, S., Togo, S., Minakata, K., Gu, T., Ohashi, R., Tajima, K., Murakami, A., Iwakami, S., Zhang, J., Xie, C., et al. (2010) · PubMed · Cited by 21
Petersen, R. C., & Richelson, E. (1982) · Psychopharmacology · doi:10.1007/bf00430749 · Cited by 17
Cited by
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Self-citationZanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Rudin, C. M., Brambilla, E., Faivre-Finn, C., & Sage, J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00235-0 · Cited by 1,570
Self-citationSen, T., Rodriguez, B. L., Chen, L., Corte, C. M. D., Morikawa, N., Fujimoto, J., Cristea, S., Nguyen, T., Diao, L., Li, L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1020 · Cited by 902
Self-citationCysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Olson, O. C., & Joyce, J. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4027 · Cited by 699
Metadata
- Authors
- Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.-F., Vaka, D., Tran, K. Q. T., Zhou, M., Krasinska, K., Riess, J. W., Neal, J. W., Khatri, P., Park, K. S., Butte, A. J., & Sage, J.
- Venue
- Cancer Discovery
- Published
- 2013-12-01
- Volume
- 3
- Issue
- 12
- Pages
- 1364-1377
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2097834966
- Cited by
- 358
- References
- 44
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.